Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
TheBody.com/TheBodyPRO.com cover the XIX International AIDS Conference (AIDS 2012)
  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
International News

Drug Treatments, Scientific Advances Fuel Hope for HIV Control as AIDS 2012 Conference Draws Near

July 16, 2012

"A cure for AIDS remains a distant prospect but a host of drug treatments and other advances have fueled fresh hope that new [HIV] infections may someday be halted for good," Agence France-Presse reports. "Strategies for ending the 30-year AIDS epidemic through advances in treatment, testing and prevention are high on the agenda of" the XIX International AIDS Conference, "when it returns to the United States next week after two decades," according to the news agency (Sheridan, 7/14). "Thanks to drugs that can control the virus for decades, AIDS is no longer a death sentence," Reuters writes in an article examining AIDS vaccine research. "New infections have fallen by 21 percent since the peak of the pandemic in 1997 and advances in prevention -- through voluntary circumcision programs, prevention of mother-to-child transmission and early treatment -- promise to cut that rate even more," the news service states (Steenhuysen, 7/15).

Gottfried Hirnschall, director of the WHO's HIV Department, said in an interview with AFP, "The key is figuring out how to best manage the latest advances." He added these strategies will be "a central conversation at the conference -- the appropriate initiation for treatment and also how to best take advantage of antiretrovirals for prevention more broadly speaking," the news service notes (Sheridan, 7/16). NPR's "Shots" blog examines the impact of generic AIDS drugs made available through PEPFAR, writing, "Since 2003, much of the treatment dispensed in hard-hit countries has come in the form of generic versions of previously expensive drugs." The blog highlights a study published in Health Affairs last week (Aguirre, 7/13).

Back to other news for July 2012


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
AIDS 2012 Pre-Conference News & Information

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:



Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.


Advertisement